Elevated levels of specific circulating antibodies reflect the immune system’s response to disease. In healthy individuals, these antibodies could indicate a future risk of disorders. They also offer critical insights into disease progression, molecular subtypes, and treatment responses.
By measuring antibody binding to hundreds or thousands of protein antigens in a single assay, we can discover and validate highly predictive biomarkers—including those directly associated with pathological processes—for earlier disease detection and improved patient outcomes.
